Does LEUPROLIDE Cause Device defective? 108 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Device defective have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.2% of all adverse event reports for LEUPROLIDE.
108
Reports of Device defective with LEUPROLIDE
0.2%
of all LEUPROLIDE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Device defective From LEUPROLIDE?
Of the 108 reports, 1 (0.9%) required hospitalization.
Is Device defective Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 108 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Device defective?
SOMATROPIN (1,719)
USTEKINUMAB (1,071)
SECUKINUMAB (666)
GUSELKUMAB (574)
GOLIMUMAB (539)
ABATACEPT (458)
ALBUTEROL (445)
TOCILIZUMAB (400)
INSULIN GLARGINE (397)
EXENATIDE (387)
Which LEUPROLIDE Alternatives Have Lower Device defective Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM